Webinar
August 20, 2024 1:00 PM

Historically, trends in branded product pricing have shown predictable year-over-year increases until a generic entrant entered the market. However, 2024 witnessed an unprecedented proliferation of wholesale acquisition cost (WAC) cuts across the pharmaceutical industry.

In part 2 of our 3-part webinar series, we explored the magnitude of these cuts in comparison with aggregate trends of previous years.

In this webinar, we dived deep into:

• Price Cuts in 2024: Analyzed the extent of branded product price reductions and the factors driving these changes, including regulatory responses, generic launches, and other influential variables.
• Balancing Channels & Affordability: Learned about pricing and physical access strategies that manufacturers can use to manage the needs of different distribution channels while still making products more affordable for patients.
• Optimizing the Product Life Cycle: Discovered key stages within a product’s life cycle where these strategies can be implemented for maximum impact. We will discuss preemptive price cuts and product lifecycle pricing considerations.

Katie Herrick
Principal Consultant

Dan DiGiorno
Principal Consultant